Search research articles
Contact Us
Filters
Showing results (231-240 of 356) with videos related to
Page
of 36
Sort By:
The Lancet. Respiratory Medicine
|
February 8, 2018
Validation of multidisciplinary diagnosis in IPF
Diego Castillo, Simon Walsh, David M Hansell, et al.
Multiple Sclerosis and Related Disorders
|
November 2, 2019
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients
Assunta Bianco, Pier-Valerio Mari, Anna Rita Larici, et al.
BMC Pulmonary Medicine
|
March 21, 2023
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study
Linrui Xu, Giacomo Sgalla, Faping Wang, et al.
The European Respiratory Journal
|
May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Harold R Collard, Luca Richeldi, Dong Soon Kim, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 4, 2024
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life
Luca Richeldi, Pietro Schino, Elena Bargagli, et al.
ERJ Open Research
|
October 13, 2016
Acute myocardial infarction <i>versus</i> other cardiovascular events in community-acquired pneumonia
Stefano Aliberti, Julio Ramirez, Roberto Cosentini, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
September 24, 2024
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Giorgio Monteleone, ILDs Study Group Sip/Irs, Laura Bergantini, et al.
Respiratory Medicine
|
January 13, 2021
Suggestions for lung function testing in the context of COVID-19
Manlio Milanese, Angelo Guido Corsico, Salvatore Bellofiore, et al.
The Lancet. Respiratory Medicine
|
December 3, 2014
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wim A Wuyts, Katerina M Antoniou, Keren Borensztajn, et al.
Respiratory Medicine
|
May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
Luca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Page
of 36
Search research articles
Search
Showing results (231-240 of 356) with videos related to
Sort By:
Page
of 36
The Lancet. Respiratory Medicine
|
February 8, 2018
Validation of multidisciplinary diagnosis in IPF
Diego Castillo, Simon Walsh, David M Hansell, et al.
Multiple Sclerosis and Related Disorders
|
November 2, 2019
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients
Assunta Bianco, Pier-Valerio Mari, Anna Rita Larici, et al.
BMC Pulmonary Medicine
|
March 21, 2023
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study
Linrui Xu, Giacomo Sgalla, Faping Wang, et al.
The European Respiratory Journal
|
May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Harold R Collard, Luca Richeldi, Dong Soon Kim, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 4, 2024
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life
Luca Richeldi, Pietro Schino, Elena Bargagli, et al.
ERJ Open Research
|
October 13, 2016
Acute myocardial infarction <i>versus</i> other cardiovascular events in community-acquired pneumonia
Stefano Aliberti, Julio Ramirez, Roberto Cosentini, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
September 24, 2024
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Giorgio Monteleone, ILDs Study Group Sip/Irs, Laura Bergantini, et al.
Respiratory Medicine
|
January 13, 2021
Suggestions for lung function testing in the context of COVID-19
Manlio Milanese, Angelo Guido Corsico, Salvatore Bellofiore, et al.
The Lancet. Respiratory Medicine
|
December 3, 2014
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wim A Wuyts, Katerina M Antoniou, Keren Borensztajn, et al.
Respiratory Medicine
|
May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
Luca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Page
of 36